LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression
- PMID: 32058222
- DOI: 10.1016/j.biopha.2020.109987
LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression
Abstract
Long non-coding RNA (lncRNA) LINC00173 has been previously shown to promote chemoresistance and progression of small-cell lung cancer. Herein, we examine the clinical significance and biological function of LINC00173 in triple-negative breast cancer (TNBC). Quantitative PCR analysis was performed to determine the expression of LINC00173 in TNBC and adjacent breast tissues (n = 84). The associations of LINC00173 expression with cancer features and survival of TNBC patients were analyzed. The function of LINC00173 in TNBC cell proliferation, colony formation, and invasion was explored. TNBCs expressed increased levels of LINC00173 relative to normal breast tissues. TNBC patients with high tumoral LINC00173 levels had a lower recurrence-free survival and overall survival rate than those with low LINC00173 expression. Silencing of LINC00173 inhibited the proliferation, colony formation, and invasion of TNBC cells, whereas overexpression of LINC00173 exerted opposite effects. In vivo studies confirmed the reduction of tumor growth by LINC00173 depletion. Mechanistic investigation revealed that LINC00173 suppressed miR-490-3p to promote aggressive phenotype in TNBC cells. There was an inverse correlation between miR-490-3p and LINC00173 in TNBC (r = -0.2647, P = 0.0149). Altogether, LINC00173 functions as an oncogene in TNBC through antagonization of miR-490-3p. Upregulation of LINC00173 is associated with poor prognosis in TNBC. Targeting LINC00173 provides a potential therapeutic strategy for TNBC.
Keywords: Breast cancer; Invasion; Oncogene; Prognosis; Tumorigenesis.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest There are none.
Similar articles
-
LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7445-7456. doi: 10.26355/eurrev_201909_18854. Eur Rev Med Pharmacol Sci. 2019. PMID: 31539132
-
Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.BMC Cancer. 2016 Feb 25;16:160. doi: 10.1186/s12885-016-2108-5. BMC Cancer. 2016. PMID: 26917489 Free PMC article.
-
LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.Biosci Rep. 2019 Sep 3;39(9):BSR20190489. doi: 10.1042/BSR20190489. Print 2019 Sep 30. Biosci Rep. 2019. PMID: 31399501 Free PMC article.
-
Progress of non-coding RNAs in triple-negative breast cancer.Life Sci. 2021 May 1;272:119238. doi: 10.1016/j.lfs.2021.119238. Epub 2021 Feb 16. Life Sci. 2021. PMID: 33600860 Review.
-
A review on the role of LINC00173 in human cancers.Pathol Res Pract. 2023 Mar;243:154351. doi: 10.1016/j.prp.2023.154351. Epub 2023 Feb 3. Pathol Res Pract. 2023. PMID: 36774758 Review.
Cited by
-
PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma.Aging (Albany NY). 2024 Jul 5;16(14):11339-11358. doi: 10.18632/aging.206009. Epub 2024 Jul 5. Aging (Albany NY). 2024. PMID: 39029955 Free PMC article.
-
Long non-coding RNA LINC00173 enhances cisplatin resistance in hepatocellular carcinoma via the microRNA-641/RAB14 axis.Oncol Lett. 2021 May;21(5):371. doi: 10.3892/ol.2021.12632. Epub 2021 Mar 13. Oncol Lett. 2021. PMID: 33777195 Free PMC article.
-
Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior.Cancers (Basel). 2021 Dec 13;13(24):6256. doi: 10.3390/cancers13246256. Cancers (Basel). 2021. PMID: 34944876 Free PMC article.
-
Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition.Cancer Cell Int. 2021 Sep 26;21(1):515. doi: 10.1186/s12935-021-02213-2. Cancer Cell Int. 2021. PMID: 34565361 Free PMC article.
-
Emerging roles and biomarker potential of WNT6 in human cancers.Cell Commun Signal. 2024 Nov 11;22(1):538. doi: 10.1186/s12964-024-01892-4. Cell Commun Signal. 2024. PMID: 39529066 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources